Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Monday 24 August 2015 7:07 pm

New flu vaccine could give humans life-long immunity

By: Sarah Spickernell

Add as a preferred source on Google

A new vaccine created by scientists in the US could give humans life-long immunity to influenza and help prevent future pandemics.
 
Read more: Yorkshire duck farm bird flu outbreak: How is the disease transmitted and can it affect humans?
 
Vaccines are already available for preventing the illness, but as soon as the virus mutates these become redundant and new ones must be developed. 
 
The mutation rate of influenza is high and as a result a new vaccine is recommended each year. Huge sums of money end up being pumped into research in this area.
 
But this could soon change thanks to the latest discovery. If the vaccine passes full human trials and is fully developed by a pharmaceutical company, people will only need to have the jab once. 
 
Read more: Suspected bird flu found in Lancashire
 
In initial animal tests, the results of which are published in the journals Science and Nature Medicine, the vaccine was able to give life-long immunity to multiple strains.
 
This is because, unlike traditional vaccines which have always targeted a part of the virus that is susceptible to mutation, this vaccine targets a permanent part of the virus that does not change. 
 
It could be a major help in preventing major flu outbreaks occurring again in the future, such as the 2009 H1N1 swine flu pandemic that killed more than 16,000 people worldwide.
 
Sarah Gilbert, professor of vaccinology at Oxford University, said: 
 
This is an exciting development, but the new vaccines now need to be tested in clinical trials to see how well they work in humans. 
 
This will be the next stage of research, which will take several years. So we are still some way from having better flu vaccines for humans.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Lloyds Bank and Halifax users unable to use app in latest outage

  • Economists urge Bank of England to halt bond sales as borrowing costs climb

More from Morning Wire

  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • The best weapon against AI slop is a good lunch

    Opinion
    Pub in Leadenhall Market, London
  • Plaud Unveils Plaud One Explorer Edition, the Wearable AI Earbuds Built for the Agent Era

    Business Wire
  • Vercel Appoints Amit Agarwal, Standard Template Labs CEO and former Datadog President, to Board of Directors

    Business Wire
  • Claude to watermark AI ‘slop’ – including edited human writing

    Tech
    Smartphone displaying the Claude by Anthropic AI assistant app, showing the app icon and interface.
  • Dolly Parton: The rhinestone capitalist

    Opinion
    Dollywood gift shop with Dolly Parton t-shirt, books, mugs, and colorful floral display. A person browses merchandise.
  • A tribute to wine legend Matthew Jukes by his friend Libby Brodie

    Life&Style
    Libby Brodie and Matthew Jukes raising a toast at a celebratory event, smiling and holding a glass, conveying joy and success
  • Cloudflare Gives AI Agents an Identity and a Wallet

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook